VALN (Valneva SE) Stock Market Reviews

crown

search

Read and share opinions on VALN (Valneva SE) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

VALN

Valneva SE

clarify Biotechnology

bookmark Healthcare

public France

Sell Neutral Buy

Latest News

VALNEVA Declaration of shares and voting rights: October 31, 2025
Nov 5, 2025
Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Nov 4, 2025
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Oct 27, 2025
Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates
Oct 6, 2025
VALNEVA Declaration of shares and voting rights: September 30, 2025
Oct 6, 2025
Valneva Reports 95% Seroresponse Four Years After Single Shot of Chikungunya Vaccine IXCHIQ®
Sep 30, 2025
VALNEVA Declaration of shares and voting rights: August 31, 2025
Sep 3, 2025
Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate
Sep 3, 2025
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Aug 25, 2025
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older
Aug 18, 2025
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Aug 12, 2025
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Aug 7, 2025

Reviews